Skip to main content

Table 2 Baseline characteristics of the included studies

From: Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis

Study Group Age
Mean
(SD)
Sex
No. of Female/Male
Weight
Mean
(SD)
BMI
Mean
(SD)
SBP
Mean
(SD)
FBG
Mean
(SD)
Duration– yr.
Mean
(SD)
Smoker – no. (%)
Brasnyo et al. Resveratrol
Placebo
57·9(7·9)
52.5(11.1)
NA 90.1(16.3)
105.3(16.7)
NA 140(12)
140(17)
7.9(2.21)
8.8(3.2)
NA 0(10)
0(9)
Bhatt et al. Resveratrol
Placebo
56.67(8.91)
57.75(8.71)
16/12
20/9
64.78(9.25)
63.1(9.02)
24.66(3.57)
24.92(3.05)
139.71(16.10)
134.51(14.61)
11.82(3.58)
10.11(2.56)
7.57(4.56)
6.68(4.7)
6/28
6/29
Movahed et al. Resveratrol
Placebo
52.45(6.18)
51.81(6.99)
17/16
16/17
74.26(11.39)
76.60(14.27)
27.05(3.13)
27.83(4.12)
129.03(14.91)
129.31(15.16)
9.76(2.76)
8.40(2.86)
5.81(1.53)
5.39(1.36)
7(21.9)
4.(12.9)
Goh et al. Resveratrol
Placebo
55.8(7.3)
56.3(6.0)
NA 87.0(26.6)
68.3(13.7)
29.4(6.8)
24.4(3.6)
NA 11.8(2.9)
9.5(1.0)
9.4(5.3)
9.6(6.3)
1(10)
2(20)
Tome-Carneiro et al. Resveratrol
Placebo
63(12)
58(10)
NA 84(11)
85(16)
31(5.1)
32(4.5)
130(16)
129(21)
8.39(3)
8.22(2)
NA 2(22)
8(36)
Bashmakov et al. Resveratrol
Placebo
54.0(10.1)
59.8(6.6)
6/8
3/7
NA 28(3.5)
29(2.5)
NA NA 15(6.9)
15.2(9.5)
3(21)
1(10)
Thazhath et al. Resveratrol
Placebo
NA NA 81.1(3.7)
81.1(4.3)
NA NA 8.1(0.3)
8.2(0.3)
NA NA
Timmers et al. Resveratrol
Placebo
NA NA NA NA 138(11.8)
141(11.7)
7.80(1.62)
7.70(1.70)
NA NA
Javid et al. Resveratrol
Placebo
49.1(7.4)
50.9(8.9)
16/5
18/4
73.8(10.2)
70.95(11)
29.3(4.9)
28.3(4.8)
NA 8.5(3.1)
9.4(3.0)
NA NA
  1. BMI body mass index, SBP systolic blood pressure, FBG fasting blood glucose